New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe-Reference-Cited by-同舟云学术

New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe

Published:2024-03 Issue: Volume:38 Page:100840
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Houda Ilias^ORCID,Dickhoff Chris,Uyl-de Groot Carin A.,Reguart Noemi,Provencio Mariano,Levy Antonin^ORCID,Dziadziuszko Rafal,Pompili Cecilia,Di Maio Massimo,Thomas Michael,Brunelli Alessandro,Popat Sanjay,Senan Suresh,Bahce Idris^ORCID

Publisher

Elsevier BV

Reference65 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Hendriks;Ann Oncol,2023

3. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

4. Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials;Lim;J Thorac Oncol,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: outstanding contribution and entering a new phase;Japanese Journal of Clinical Oncology;2024-08-19

2. Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study;Cancers;2024-07-19

3. The Surgical Resection Difficulty From Neoadjuvant Chemoimmunotherapy Is Minimal and Neoadjuvant Therapy Should Be the Standard;Journal of Thoracic Oncology;2024-06

4. Healthcare Resource Utilization and Associated Costs among Patients with Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy or Immunotherapy in Spain: A Single-Center, Real-World, Exploratory Study;Cancers;2024-05-30

5. Retreatment with Immune Checkpoint Inhibitors in the New Scenario of Immunotherapy in Non-Small Cell Lung Cancer;Cancers;2024-04-26